GRANULOCYTE COLONY-STIMULATING FACTOR NOS for Soft tissue sarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where GRANULOCYTE COLONY-STIMULATING FACTOR NOS was used for Soft tissue sarcoma.
Most Reported Side Effects for GRANULOCYTE COLONY-STIMULATING FACTOR NOS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 350 | 15.9% | 65 | 81 |
| Product use in unapproved indication | 192 | 8.7% | 51 | 32 |
| Haematotoxicity | 186 | 8.5% | 20 | 0 |
| Off label use | 169 | 7.7% | 59 | 50 |
| Death | 167 | 7.6% | 167 | 7 |
| Neutropenia | 157 | 7.1% | 27 | 33 |
| Sepsis | 134 | 6.1% | 71 | 53 |
| Thrombocytopenia | 134 | 6.1% | 29 | 17 |
| Pyrexia | 125 | 5.7% | 23 | 51 |
| Disease progression | 119 | 5.4% | 73 | 9 |
| Mucosal inflammation | 100 | 4.6% | 39 | 28 |
| Diarrhoea | 94 | 4.3% | 22 | 18 |
| Pneumonia | 87 | 4.0% | 29 | 35 |
| Drug ineffective | 81 | 3.7% | 30 | 21 |
| Anaemia | 79 | 3.6% | 11 | 16 |
Other Indications for GRANULOCYTE COLONY-STIMULATING FACTOR NOS
Acute myeloid leukaemia (344)
Product used for unknown indication (249)
Prophylaxis (198)
Neutropenia (117)
Acute lymphocytic leukaemia (102)
Peripheral blood stem cell apheresis (66)
Stem cell therapy (62)
Diffuse large b-cell lymphoma (54)
Haematopoietic stem cell mobilisation (51)
Bone marrow conditioning regimen (49)
Other Drugs Used for Soft tissue sarcoma
PAZOPANIB (1,400)
DOXORUBICIN (302)
TAZEMETOSTAT HYDROBROMIDE (298)
IFOSFAMIDE (237)
CABOZANTINIB S-MALATE (192)
TRABECTEDIN (183)
NIVOLUMAB (156)
OLARATUMAB (156)
IMATINIB (124)
SUNITINIB MALATE (123)